Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is a publicly traded Healthcare sector company. As of September 9, 2026, HRMY trades at $42.15 with a market cap of $2.45B and a P/E ratio of 13.21. HRMY moved -1.09% today. Year to date, HRMY is +11.22%; over the trailing twelve months it is +22.41%. Its 52-week range spans $25.52 to $43.49. Analyst consensus is buy with an average price target of $43.67. Rallies surfaces HRMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for HRMY combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $42.15 |
| Market Cap | $2.45B |
| P/E Ratio | 13.21 |
| EPS | $3.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.49 |
| 52-Week Low | $25.52 |
| Volume | 983.23K |
| Avg Volume | 0 |
| Revenue (TTM) | $959.90M |
| Net Income | $181.27M |
| Gross Margin | 75.42% |
9 analysts cover HRMY: 0 strong buy, 4 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $43.67.